Author: Kim Boyd


Kim Boyd

Kim Boyd

Recent Posts

The State of HIOs & Plans to Participate in TEFCA

A recent study published in Health Affairs examined the current state of Health Information Organizations (HIOs) and their engagement with the Trusted Exchange Framework and...

Why the Life Science Industry Should Care About the Proposed HTI-2 Rule

In an era where data fluidity is transforming healthcare, life sciences manufacturers must stay attuned to evolving Health IT policies given that many of these policies have...

How HTI-2 Proposed Rule Aligns with Public Health Data Modernization

Welcome back to our HTI-2 series! In our previous posts, we highlighted the general aspects of the HTI-2 proposed rule, delved into API certification requirements, explored the...

ONC HTI-2 Proposed Rule: Examining ePrescribing, Prior Authorization, & RTPB

In our ongoing series about the HTI-2 proposed rule, we've previously provided a high-level overview, aspects related to API certification requirements, and information blocking....

ONC HTI-2 Proposed Rule: Navigating Information Blocking Compliance

In our ongoing series dissecting the proposed HTI-2 rule, we’ve explored its potential to revolutionize health IT infrastructure and interoperability. Today, we’re delving into...

ONC HTI-2 Proposed Rule: Understanding API Certification Requirements

In our earlier blog post, ONC HTI-2 Proposed Rule: A Leap Forward in Healthcare Interoperability, we provided a high-level overview of the proposed rule. In this post, we will...

ONC HTI-2 Proposed Rule: A Leap Forward in Healthcare Interoperability

On July 10, 2024, the Office of the National Coordinator for Health Information Technology (ONC) announced the release of the highly anticipated Health Data, Technology, and...

Part D CMS-4205-F2 Rule Summary: Compliance, Standards, and Deadlines

In an ongoing effort to enhance the efficiency, interoperability, and security of electronic health information systems, the Centers for Medicare & Medicaid Services (CMS) has...

Adapting to State Reforms in Prior Authorization Processes: Opportunities and Challenges for Healthcare Entities

As state legislatures intensify efforts to reform prior authorization processes, these changes may reflect broader regulatory trends such as those outlined by CMS in rules like...

From Federal to State: The Vital Importance of Vigilance in DEA Rule Changes and Policy Shifts for Telehealth Substance Use Disorder Treatment

The Controlled Substances Act (CSA) in the United States imposes stringent regulations governing the prescribing, dispensing, and usage of narcotic drugs, especially those...